Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-6 of 6
Keywords: Leukemia
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Oncology
Journal:
Case Reports in Oncology
Case Rep Oncol (2024) 17 (1): 788–796.
Published Online: 25 July 2024
...Darshankumar M. Raval; Ricardo J. Pagán; Shayan Butt; Libardo Rueda Prada Introduction: Chronic myeloid leukemia (CML) is a myeloproliferative disease caused by the reciprocal translocation of chromosomes 9 and 22, which leads to a chimeric gene product known as BCR-ABL. Some studies have shown...
Journal Articles
Subject Area:
Oncology
Journal:
Case Reports in Oncology
Case Rep Oncol (2023) 16 (1): 893–899.
Published Online: 12 September 2023
... patient, initially treated for neuroblastoma, developed treatment-related acute myeloid leukemia (tAML) 6 years later. Our investigation emphasizes the crucial role of EVI1 disruption in accelerating the progression of secondary tumors. This case underscores the significant risk of SMNs following...
Journal Articles
Synchronous B-Cell Acute Lymphoblastic Leukemia and Serous Ovarian Carcinoma: A Case Report
Open AccessSubject Area:
Oncology
Journal:
Case Reports in Oncology
Case Rep Oncol (2022) 14 (3): 1621–1626.
Published Online: 12 November 2021
...Michael Superdock; Justin Komisarof; Hani Katerji; Eric Huselton Adult patients with B-cell acute lymphoblastic leukemia (ALL) have higher rates of antecedent and subsequent malignancies. However, synchronous identification of ALL and ovarian cancer is exceedingly rare. We report the unique case...
Journal Articles
Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma
Open AccessSubject Area:
Oncology
Journal:
Case Reports in Oncology
Case Rep Oncol (2020) 13 (1): 207–211.
Published Online: 05 March 2020
... that there is an increase in second primary malignancy after RAI therapy amongst thyroid cancer survivors including acute myeloid leukemia (AML) as an infrequent cancer related to RAI therapy; it has a higher relative risk ratio in patients on higher doses of radiation exposure. We would like to report a 30-year-old lady...
Journal Articles
Adaptive Radiotherapy for an Uncommon Chloroma
Open AccessSubject Area:
Oncology
Journal:
Case Reports in Oncology
Case Rep Oncol (2017) 9 (3): 593–598.
Published Online: 12 October 2016
... to in the content or advertisements. Granulocytic sarcoma Chloroma Leukemia Adaptive radiotherapy Radiotherapy planning [email protected] Case Report Case Rep Oncol 2016;9:593 598 DOI: 10.1159/000450599 Published online: October 12, 2016 © 2016 The Author(s) Published by S. Karger AG...
Journal Articles
Subject Area:
Oncology
Journal:
Case Reports in Oncology
Case Rep Oncol (2015) 8 (1): 88–93.
Published Online: 13 February 2015
...Vineet Agrawal; Eric S. Christenson; Margaret M. Showel Long-term therapy with tyrosine kinase inhibitors (TKI) has resulted in improved outcomes for patients suffering from Bcr-Abl fusion protein-harboring leukemias. As a result, a growing population of patients on TKI therapy present...